Legal Representation
Attorney
Jeffrey H. Greger
USPTO Deadlines 2 active
| Deadline Type | Event Code | Deadline Date | Days Until | Priority | Extension Available |
|---|---|---|---|---|---|
|
OFFICE ACTION
Non-Final Action E-Mailed |
GNRTF | Sep 20, 2025 | 75 days | Critical | Until Dec 20, 2025 |
|
OFFICE ACTION
Non-Final Action Mailed |
CNRTR | Sep 20, 2025 | 75 days | Critical | Until Dec 20, 2025 |
Next deadline: Non-Final Action Mailed
on September 20, 2025
(75 days)
Application History
8 events| Date | Code | Type | Description |
|---|---|---|---|
| Jun 20, 2025 | CNRT | R | NON-FINAL ACTION WRITTEN |
| Jun 20, 2025 | GNRT | F | NON-FINAL ACTION E-MAILED |
| Jun 20, 2025 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Jun 18, 2025 | DOCK | D | ASSIGNED TO EXAMINER |
| Jun 6, 2025 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Jun 6, 2025 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| May 28, 2025 | MAFR | O | APPLICATION FILING RECEIPT MAILED |
| May 28, 2025 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 005
Pharmaceutical and biopharmaceutical products and preparations for medical treatment of gastrointestinal diseases and disorders emanating from microbiota dysfunction, and for treating cancers and diseases, namely, neurological, psychiatric, gastrointestinal, metabolic, inflammatory, autoimmune, and infectious diseases; Pharmaceuticals for treatment, maintaining and restoring human health in the field of disturbed microbial community, and treatment for dysbiosis, cancers, and diseases, including neurological, psychiatric, gastrointestinal, metabolic, inflammatory, autoimmune, and infectious diseases; Biological preparations in the nature of microorganisms used to treat, maintain and restore human health in the field of treatment of a disturbed microbial community, namely, for the treatment of dysbiosis, cancers, and diseases including neurological, psychiatric, gastrointestinal, metabolic, inflammatory, autoimmune, and infectious diseases
Class 010
Medical and surgical apparatus and instruments; drug delivery devices, including medical apparatus and instruments for administration of pharmaceutical and biopharmaceutical products and preparations; Drug delivery devices to treat gut microbiome-related disorders, cancers, neurological diseases, psychiatric diseases, gastrointestinal diseases, metabolic diseases, inflammatory diseases, autoimmune diseases, infectious diseases; drug delivery devices to treat gut microbiome-related disorders, cancers, neurological diseases, psychiatric diseases, gastrointestinal diseases, metabolic diseases, inflammatory diseases, autoimmune diseases, infectious diseases, in the nature of a kit comprising a prefilled suspension bag and administration tube set
Additional Information
Design Mark
The mark consists of XERVYTEG in purple and in a stylized format.
Color Claim
The color(s) purple and yellow is/are claimed as a feature of the mark.
Classification
International Classes
005
010